Advanced search
Publication Cover
Expert Review of Dermatology Volume 7, 2012 - Issue 6
Journal homepage
15
Views
1
CrossRef citations to date
0
Altmetric
Review

Improving quality of life in patients with hidradenitis suppurativa: a therapeutic view

Deirdre Nathalie Dufour Department of Dermatology, Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, Roskilde, Denmark
,
Solveig Esmann Department of Dermatology, Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, Roskilde, Denmark. [email protected]
&
Gregor BE Jemec Department of Dermatology, Roskilde Hospital, Health Sciences Faculty, University of Copenhagen, Roskilde, Denmark
Pages 549-557 | Published online: 10 Jan 2014

References

  • Jansen T, Plewig G. What’s new in acne inversa (alias hidradenitis suppurativa)? J. Eur. Acad. Dermatol. Venereol. 14(5), 342–343 (2000).
  • Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br. J. Dermatol. 164(1), 170–175 (2011).
  • von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp. Dermatol. 19(6), 533–537 (2010).
  • von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br. J. Dermatol. 164(2), 367–371 (2011).
  • Jemec GB. Clinical practice. Hidradenitis suppurativa. N. Engl. J. Med. 366(2), 158–164 (2012).
  • von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J. Eur. Acad. Dermatol. Venereol. 14(5), 389–392 (2000).
  • Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J. Am. Acad. Dermatol. 35(2 Pt 1), 191–194 (1996).
  • Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J; Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J. Am. Acad. Dermatol. 56(4), 621–623 (2007).
  • Velpeau A. In: Dictionnaire de Médecine ou Répertoire Général des Sciences Médicals Considérées sous le Rapport Théorique et Pratique. Adelon BB (Ed.). Béchet Jne, Labé, Paris, France (1839).
  • Verneuil A. Études sur les tumeurs de la peau et quelgues maladies des glandes sudoripares. Arch. Gen. Med. 4, 693–704 (1854).
  • Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J. Am. Acad. Dermatol. 34(6), 994–999 (1996).
  • Kamp S, Fiehn AM, Stenderup K et al. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br. J. Dermatol. 164(5), 1017–1022 (2011).
  • Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br. J. Dermatol. 122(6), 763–769 (1990).
  • von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp.Dermatol. 19(6), 533–537 (2010).
  • Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa – characteristics and consequences. Clin. Exp. Dermatol. 21(6), 419–423 (1996).
  • Onderdijk AJ, van der Zee HH, Esmann S et al. Depression in patients with hidradenitis suppurativa. J. Eur. Acad. Dermatol. Venereol. doi:10.1111/j.1468-3083.2012.04468.x (2012) (Epub ahead of print).
  • Dufour DN. Anxiety in Patients with Hidradenitis suppurativa. Presented at: World Congress of Dermatology. Seoul, Korea, 24–29 May 2011.
  • Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Dermatologic Surgery. Roenigk RK (Ed.). Marcel Dekker, NY, USA 729–739 (2012).
  • Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int. J. Dermatol. 22(5), 325–328 (1983).
  • Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin. Exp. Dermatol. 35(1), 36–40 (2010).
  • Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J. Am. Acad. Dermatol. 39(6), 971–974 (1998).
  • Kurzen H, Kurokawa I, Jemec GB et al. What causes hidradenitis suppurativa? Exp. Dermatol. 17(5), 455–456; discussion 457 (2008).
  • Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br. J. Dermatol. 149(1), 211–213 (2003).
  • Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br. J. Dermatol. 154(5), 977–978 (2006).
  • Gener G, Canoui-Poitrine F, Revuz JE et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology (Basel) 219(2), 148–154 (2009).
  • van der Zee HH, Boer J, Prens EP, Jemec GB. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology (Basel) 219(2), 143–147 (2009).
  • Join-Lambert O, Coignard H, Jais JP et al. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology (Basel) 222(1), 49–58 (2011).
  • Haslund P, Lee RA, Jemec GB. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm. Venereol. 89(6), 595–600 (2009).
  • Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa. Br. J. Dermatol. 165(2), 391–398 (2011).
  • Adams DR, Yankura JA, Fogelberg AC, Anderson BE. Treatment of hidradenitis suppurativa with etanercept injection. Arch. Dermatol. 146(5), 501–504 (2010).
  • Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J. Am. Acad. Dermatol. 62(2), 205–217 (2010).
  • Kimball AB, Williams D, Jemec G, Gu Y. Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week Phase II, randomized, study. J. Am. Acad. Dermatol. 66(4), AB50 (2012).
  • Kimball AB, Jemec G, Okun M, Gu Y. Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of a Phase II, randomized, double-blind study. Br. J. Dermatol. 165(Suppl. 1), AB155 (2011).
  • van Rappard DC, Leenarts MF, Meijerink-van ‘t Oost L, Mekkes JR. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa. J. Dermatolog. Treat. 23(4), 284–289 (2012).
  • Yazdanyar S, Boer J, Ingvarsson G, Szepietowski JC, Jemec GB. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology (Basel) 222(4), 342–346 (2011).
  • Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: A case series of five patients. J. Dermatolog. Treat. 17(4), 211–213 (2006).
  • Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J. R. Soc. Med. 88(5), 289–290 (1995).
  • Rose RF, Goodfield MJ, Clark SM. Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin. Exp. Dermatol. 31(1), 154–155 (2006).
  • Puri N, Talwar A. A study on the management of hidradenitis suppurativa with retinoids and surgical excision. Indian J. Dermatol. 56(6), 650–651 (2011).
  • Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. Eur. J. Pharmacol. 672(1–3), 1–8 (2011).
  • Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis 69(4), 287–288 (2002).
  • Hogan DJ, Light MJ. Successful treatment of hidradenitis suppurativa with acitretin. J. Am. Acad. Dermatol. 19(2 Pt 1), 355–356 (1988).
  • Trombetta M, Werts ED, Parda D. The role of radiotherapy in the treatment of hidradenitis suppurativa: case report and review of the literature. Dermatol. Online J. 16(2), 16 (2010).
  • Fröhlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa – still valid today? Strahlenther. Onkol. 176(6), 286–289 (2000).
  • Mahmoud BH, Tierney E, Hexsel CL, Pui J, Ozog DM, Hamzavi IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium: yttrium-aluminium-garnet laser. J. Am. Acad. Dermatol. 62(4), 637–645 (2010).
  • Xu LY, Wright DR, Mahmoud BH, Ozog DM, Mehregan DA, Hamzavi IH. Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment. Arch. Dermatol. 147(1), 21–28 (2011).
  • Highton L, Chan WY, Khwaja N, Laitung JK. Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study. Plast. Reconstr. Surg. 128(2), 459–465 (2011).
  • Revuz J. Hidradenitis suppurativa. J. Eur. Acad. Dermatol. Venereol. 23(9), 985–998 (2009).
  • van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J. Am. Acad. Dermatol. 63(3), 475–480 (2010).
  • Buimer MG, Ankersmit MF, Wobbes T, Klinkenbijl JH. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol. Surg. 34(2), 224–227 (2008).
  • Lapins J, Marcusson JA, Emtestam L. Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique. Br. J. Dermatol. 131(4), 551–556 (1994).
  • Smith HS, Chao JD, Teitelbaum J. Painful hidradenitis suppurativa. Clin. J. Pain 26(5), 435–444 (2010).
  • Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br. J. Dermatol. 161(4), 831–839 (2009).
  • Sabat R, Chanwangpong A, Schneider-Burrus S et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS ONE 7(2), e31810 (2012).
  • Amano M, Grant A, Kerdel FA. A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa. Int. J. Dermatol. 49(8), 950–955 (2010).
  • Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J. Am. Acad. Dermatol. 40(1), 73–76 (1999).
  • Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm. Venereol. 91(3), 328–332 (2011).
  • Solarski ST. Living with hidradenitis suppurativa. Dermatol. Nurs. 16(5), 447–449 (2004).
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin. Exp. Dermatol. 19(3), 210–216 (1994).
  • von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br. J. Dermatol. 144(4), 809–813 (2001).
  • Sartorius K, Killasli H, Heilborn J, Jemec GB, Lapins J, Emtestam L. Interobserver variability of clinical scores in hidradenitis suppurativa is low. Br. J. Dermatol. 162(6), 1261–1268 (2010).
  • Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm. Venereol. 90(3), 264–268 (2010).
  • Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J. Am. Acad. Dermatol. 62(4), 706–708, 708.e1 (2010).
  • Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol. Clin. 28(4), 779–793 (2010).
  • Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br. J. Dermatol. 143(5), 983–991 (2000).
  • Picardi A, Pasquini P, Abeni D, Fassone G, Mazzotti E, Fava GA. Psychosomatic assessment of skin diseases in clinical practice. Psychother. Psychosom. 74(5), 315–322 (2005).
  • Fried RG, Hussain SH. Nonpharmacologic management of common skin and psychocutaneous disorders. Dermatol. Ther. 21(1), 60–68 (2008).
  • Glaser R, Kiecolt-Glaser JK, Marucha PT, MacCallum RC, Laskowski BF, Malarkey WB. Stress-related changes in proinflammatory cytokine production in wounds. Arch. Gen. Psychiatry 56(5), 450–456 (1999).
  • Garg A, Chren MM, Sands LP et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch. Dermatol. 137(1), 53–59 (2001).
  • Spiegel D. Healing words: emotional expression and disease outcome. JAMA 281(14), 1328–1329 (1999).
  • Shenefelt PD. Psychological interventions in the management of common skin conditions. Psychol. Res. Behav. Manag. 3, 51–63 (2010).
  • Jafferany M, Vander Stoep A, Dumitrescu A, Hornung RL. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Int. J. Dermatol. 49(7), 784–789 (2010).
  • Shenefelt PD. Psychodermatological disorders: recognition and treatment. Int. J. Dermatol. 50(11), 1309–1322 (2011).
  • Shah N. Hidradenitis suppurativa: a treatment challenge. Am. Fam. Physician 72(8), 1547–1552 (2005).
  • Krbec AC. Current understanding and management of hidradenitis suppurativa. J. Am. Acad. Nurse Pract. 19(5), 228–234 (2007).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.